Earnest Partners 13F: Adds $4.8M to Cabot (CBT) Stake

An institutional filing shows Earnest Partners raised its holdings in specialty chemicals maker Cabot Corporation.

Reviewed by automated data checks against the source filing. How we make and check alerts

Earnest Partners added 52,703 shares to its stake in Cabot Corporation ($CBT), a 1.70% increase, according to a 13F filing with the SEC dated May 15, 2026. It reported 3,158,617 shares worth $286.87 million at the end of the quarter.

Since the filing, $CBT is up 3.0% after 1 week, up 10.7% after 1 month and down 7.3% to date (from the $80.11 close on May 15, 2026).

Find the original: Earnest Partners 13F filings on SEC EDGAR

CBT Cabot Corporation
$74.29 +12.70% year to date
Daily close · Oct 16, 2026

Key Points

  • Earnest Partners boosted its stake in Cabot Corporation by 1.7% during the period, adding 52,703 shares.
  • Earnest Partners held 3,158,617 $CBT shares at quarter end, up 1.70% from the prior quarter.
  • Cabot Corporation shares trade around $90.82, backed by a trailing P/E ratio of 21.45 and a forward P/E of 10.96.
  • Insiders including senior executives purchased small batches of stock on June 12, 2026, while Wall Street firms maintain mixed views.

Get $CBT trade alerts by text

We text you when insiders, Congress or big funds trade $CBT. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Cabot Corporation alert may contain errors. Disclosures

Earnest Partners Increases Cabot Holdings

Institutional investor Earnest Partners grew its stake in Cabot Corporation (NYSE:CBT) during the period ended May 15, 2026, according to a Form 13F filing submitted to the SEC. The filing reflects holdings as of that reporting date and might not represent the fund's current position today. Earnest Partners raised its investment by purchasing 52,703 additional shares, lifting its total count to 3,158,617 shares. The reported value of the position stood at roughly $286.9 million.

Growth in the Position

The fund previously held 3,105,914 shares of the specialty chemicals provider. This adjustment represented a 1.7% increase in the portfolio's share count. Because 13F filings look backward at completed quarters, the disclosed totals capture past portfolio choices rather than live trading activity.

Cabot Stock Performance

Cabot shares traded near $90.82 recently, moving inside a 52-week band spanning from $58.33 to $94.53. The company carries a market capitalization of nearly $4 billion. Its trailing price-to-earnings ratio sits at 21.45, while the forward P/E rests at 10.96 based on projected earnings.

Insider Buying and Selling at Cabot Corporation

Company insiders made small purchases of stock on June 12, 2026. Douglas Delgrosso acquired 28 shares at a price of $87.65 for a total value of $2,454.20. Masterson William III, who serves as a Senior Vice President, bought 3 shares at the same price of $87.65 totaling $262.95.

Analysts Set New Price Targets

Financial firms have updated their outlooks on the specialty chemicals producer across recent months. Mizuho maintained a neutral rating on June 25, 2026, setting a target of $90.00. UBS maintained a neutral rating on August 5, 2026, lowering its target from $97.00 to $92.00, and later maintained a neutral rating on October 5, 2026, with an $86.00 target. JP Morgan maintained an underweight rating on August 7, 2026, raising its target from $70.00 to $78.00. Overall, the stock holds a consensus mean price target of $91.33 across six analyst opinions.

Inside Cabot Corporation

Headquartered in Boston, Massachusetts, Cabot Corporation manufactures specialty chemicals and performance materials. The company produces reinforcing carbons for tires and industrial goods, along with specialized carbon additives used in inks, coatings, and lithium-ion batteries for electric vehicles. Founded back in 1882, the firm operates across global markets through distribution networks and sales representatives.

What to Watch at Cabot Corporation

Market participants will look toward Cabot Corporation's next earnings report, which is scheduled for November 2, 2026, to check on profitability and revenue growth. Further institutional disclosures will clarify whether Earnest Partners continues adding to its position or holds steady in upcoming quarters.

Source: Earnest Partners's 13F filing on $CBT (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Earnest Partners 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $CBT trade alerts by text